Abstract
High blood pressure is the main cardiovascular risk factor even in the elderly. In particular, with aging, elevated systolic blood pressure becomes more important as a risk factor than does diastolic blood pressure both in males and in females. This epidemiological consideration, derived mainly from studies such as the Framingham Study, has been confirmed by several therapeutic international trials on high blood pressure in the elderly (e.g.) the Veteran Administration Cooperative Study on Antihypertensive agents, the Australian Therapeutic Trial in Mild Hypertension, the European Working Party on Blood Pressure in the Elderly, the SHEP Study and the STOP-Hypertension. These trials have demonstrated that pharmacological treatment of hypertension reduces cardiovascular mortality and morbidity even in elderly patients. However, further studies are necessary to evaluate the effects of other drugs, such as calcium antagonists, angiotensin converting enzyme inhibitors and the new angiotensin II receptor antagonists.
| Original language | Italian |
|---|---|
| Pages (from-to) | 483-487 |
| Number of pages | 5 |
| Journal | Giornale di Gerontologia |
| Volume | 44 |
| Issue number | 8-9 |
| Publication status | Published - 1996 |
Fingerprint
ASJC Scopus subject areas
- Ageing
- Geriatrics and Gerontology
Cite this
Attualita in tema di terapia antiipertensiva dell'anziano. / Rappelli, A.; Dessi-Fulgheri, P.
In: Giornale di Gerontologia, Vol. 44, No. 8-9, 1996, p. 483-487.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Attualita in tema di terapia antiipertensiva dell'anziano
AU - Rappelli, A.
AU - Dessi-Fulgheri, P.
PY - 1996
Y1 - 1996
N2 - High blood pressure is the main cardiovascular risk factor even in the elderly. In particular, with aging, elevated systolic blood pressure becomes more important as a risk factor than does diastolic blood pressure both in males and in females. This epidemiological consideration, derived mainly from studies such as the Framingham Study, has been confirmed by several therapeutic international trials on high blood pressure in the elderly (e.g.) the Veteran Administration Cooperative Study on Antihypertensive agents, the Australian Therapeutic Trial in Mild Hypertension, the European Working Party on Blood Pressure in the Elderly, the SHEP Study and the STOP-Hypertension. These trials have demonstrated that pharmacological treatment of hypertension reduces cardiovascular mortality and morbidity even in elderly patients. However, further studies are necessary to evaluate the effects of other drugs, such as calcium antagonists, angiotensin converting enzyme inhibitors and the new angiotensin II receptor antagonists.
AB - High blood pressure is the main cardiovascular risk factor even in the elderly. In particular, with aging, elevated systolic blood pressure becomes more important as a risk factor than does diastolic blood pressure both in males and in females. This epidemiological consideration, derived mainly from studies such as the Framingham Study, has been confirmed by several therapeutic international trials on high blood pressure in the elderly (e.g.) the Veteran Administration Cooperative Study on Antihypertensive agents, the Australian Therapeutic Trial in Mild Hypertension, the European Working Party on Blood Pressure in the Elderly, the SHEP Study and the STOP-Hypertension. These trials have demonstrated that pharmacological treatment of hypertension reduces cardiovascular mortality and morbidity even in elderly patients. However, further studies are necessary to evaluate the effects of other drugs, such as calcium antagonists, angiotensin converting enzyme inhibitors and the new angiotensin II receptor antagonists.
KW - antihypertensive drugs
KW - elderly
KW - hypertension
KW - systolic hypertension
UR - http://www.scopus.com/inward/record.url?scp=0030435212&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0030435212&partnerID=8YFLogxK
M3 - Articolo
AN - SCOPUS:0030435212
VL - 44
SP - 483
EP - 487
JO - Giornale di Gerontologia
JF - Giornale di Gerontologia
SN - 0017-0305
IS - 8-9
ER -